Rogers, C.G.; Koduru, S.V.; Gulati, A.; Halim, A.B.
PROSTest, a Novel Liquid Biopsy Molecular Assay, Accurately Guides Prostate Cancer Biopsy Decision-Making in Men with Elevated PSA Irrespective of DRE Findings. Cancers 2025, 17, 3908.
https://doi.org/10.3390/cancers17243908
AMA Style
Rogers CG, Koduru SV, Gulati A, Halim AB.
PROSTest, a Novel Liquid Biopsy Molecular Assay, Accurately Guides Prostate Cancer Biopsy Decision-Making in Men with Elevated PSA Irrespective of DRE Findings. Cancers. 2025; 17(24):3908.
https://doi.org/10.3390/cancers17243908
Chicago/Turabian Style
Rogers, Craig G., Srinivas V. Koduru, Anthony Gulati, and Abdel B. Halim.
2025. "PROSTest, a Novel Liquid Biopsy Molecular Assay, Accurately Guides Prostate Cancer Biopsy Decision-Making in Men with Elevated PSA Irrespective of DRE Findings" Cancers 17, no. 24: 3908.
https://doi.org/10.3390/cancers17243908
APA Style
Rogers, C. G., Koduru, S. V., Gulati, A., & Halim, A. B.
(2025). PROSTest, a Novel Liquid Biopsy Molecular Assay, Accurately Guides Prostate Cancer Biopsy Decision-Making in Men with Elevated PSA Irrespective of DRE Findings. Cancers, 17(24), 3908.
https://doi.org/10.3390/cancers17243908